The global biomedical warming and thawing devices market was valued at $159.3 million in 2021, and is projected to reach $376.7 million by 2031, registering a CAGR of 9.1% from 2022 to 2031. Biomedical warming and thawing devices are typically used to defrost samples of blood, tissues, cells, and other biologics. Cryopreservation is known as a method of successfully and safely preserving cells and tissues at a lower temperature, often below freezing point. It is therefore necessary to defrost these biological products before use, and in this case, biomedical warming and thawing equipment play a crucial role by assisting in the warming and defrosting of cryopreserved products.
They also reduce the possibility that cryo-preservative chemicals would harm these objects, as extended exposure to such chemicals might impair the preserved materials' living cells and other components. For stored cells to remain effective and viable for use in medical procedures, the use of biomedical warming and thawing devices is essential.
The biomedical warming and thawing devices market is anticipated to develop as more cryopreservation techniques are used to preserve cells and tissues. Increased demand for automated biomedical warming and thawing equipment is also helping the market grow. Growing need for pharmaceutical research is also anticipated to boost the rate of adoption for biomedical warming and thawing devices, thus, driving the market growth during the forecast period. The biomedical warming and thawing devices market is driven by rise in the number of blood banks and blood infusion centers, numerous advantages offered by automatic biomedical warming and thawing devices, and increase in the number of road accidents and trauma cases leading to blood transfusions. Biomedical warming and thawing devices are used in blood bank for preservation of plasma, stem cells, whole blood & RBCs (red blood cells), and platelets. Thus, increase in the number of blood banks and blood infusion centers is anticipated to drive the market growth.
Moreover, surge in demand for blood donation causes increase in the usage of warming and thawing devices for preservation of blood. Thus, this factor is anticipated to fuel the growth of the market. For instance, according to the World Health Organization, in 2020, globally, 118.5 million blood donations are collected each year. Around 85 million units of blood are given to patients each year. As per the same source, up to 54% of blood transfusions were given to children under 5 years of age in low-income countries; whereas, the most frequently transfused patient group was over 60 years of age, accounting for up to 75% of all transfusions in high-income countries.
Biomedical warming and thawing devices have a wide range of applications in pharmaceutical and biotechnology field for various research and studies, tissue culturing, and animal & plant engineering. Moreover, surge in number of patients for admission in medical emergency departments and rise in the number of road traffic accidents resulting in need of blood transfusion. Thus, these factors increase the demand for biomedical warming and thawing devices, which fuels the market growth. In addition, technological advancement in the healthcare sector and rise in R&D activities drive the growth of the biomedical warming and thawing devices market. On the other hand, strict regulation related to thawed biomedical products and samples and use of cryopreserved are anticipated to hinder the growth of the market. In addition, technical concerns, such as low survival biomaterial sample loss of cellular characteristics, altered gene expression, epigenic changes, and shift in protein composition are expected to limit the growth of the biomedical warming and thawing devices market.
The biomedical warming and thawing devices market is segmented on the basis of product, sample, end user, and region. On the basis of product, the market is segmented into manual and automatic. On the basis of sample market is segmented into blood products, stem cells, embryo, ovum, and others. Blood products is further bifurcated into plasma, & RBCs. By end user, the market is bifurcated into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and blood banks & stem cell banks. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biomedical warming and thawing devices market include, Barkey GmbH & co. kg, Boekel Scientific, Cardinal Health, Conroy Medical AB., Cytiva, CytoTherm, Eppendorf, Farrar Scientific, Fisher Scientific PTE LTD (Thermo Fisher Scientific), FreMon Scientific, Inc., GE, Helmer Scientific, KW Apparecchi Scientifici, Sarstedt AG & Co. KG, Sartorius AG, and Thaw World Medical Ltd.
They also reduce the possibility that cryo-preservative chemicals would harm these objects, as extended exposure to such chemicals might impair the preserved materials' living cells and other components. For stored cells to remain effective and viable for use in medical procedures, the use of biomedical warming and thawing devices is essential.
The biomedical warming and thawing devices market is anticipated to develop as more cryopreservation techniques are used to preserve cells and tissues. Increased demand for automated biomedical warming and thawing equipment is also helping the market grow. Growing need for pharmaceutical research is also anticipated to boost the rate of adoption for biomedical warming and thawing devices, thus, driving the market growth during the forecast period. The biomedical warming and thawing devices market is driven by rise in the number of blood banks and blood infusion centers, numerous advantages offered by automatic biomedical warming and thawing devices, and increase in the number of road accidents and trauma cases leading to blood transfusions. Biomedical warming and thawing devices are used in blood bank for preservation of plasma, stem cells, whole blood & RBCs (red blood cells), and platelets. Thus, increase in the number of blood banks and blood infusion centers is anticipated to drive the market growth.
Moreover, surge in demand for blood donation causes increase in the usage of warming and thawing devices for preservation of blood. Thus, this factor is anticipated to fuel the growth of the market. For instance, according to the World Health Organization, in 2020, globally, 118.5 million blood donations are collected each year. Around 85 million units of blood are given to patients each year. As per the same source, up to 54% of blood transfusions were given to children under 5 years of age in low-income countries; whereas, the most frequently transfused patient group was over 60 years of age, accounting for up to 75% of all transfusions in high-income countries.
Biomedical warming and thawing devices have a wide range of applications in pharmaceutical and biotechnology field for various research and studies, tissue culturing, and animal & plant engineering. Moreover, surge in number of patients for admission in medical emergency departments and rise in the number of road traffic accidents resulting in need of blood transfusion. Thus, these factors increase the demand for biomedical warming and thawing devices, which fuels the market growth. In addition, technological advancement in the healthcare sector and rise in R&D activities drive the growth of the biomedical warming and thawing devices market. On the other hand, strict regulation related to thawed biomedical products and samples and use of cryopreserved are anticipated to hinder the growth of the market. In addition, technical concerns, such as low survival biomaterial sample loss of cellular characteristics, altered gene expression, epigenic changes, and shift in protein composition are expected to limit the growth of the biomedical warming and thawing devices market.
The biomedical warming and thawing devices market is segmented on the basis of product, sample, end user, and region. On the basis of product, the market is segmented into manual and automatic. On the basis of sample market is segmented into blood products, stem cells, embryo, ovum, and others. Blood products is further bifurcated into plasma, & RBCs. By end user, the market is bifurcated into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and blood banks & stem cell banks. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biomedical warming and thawing devices market include, Barkey GmbH & co. kg, Boekel Scientific, Cardinal Health, Conroy Medical AB., Cytiva, CytoTherm, Eppendorf, Farrar Scientific, Fisher Scientific PTE LTD (Thermo Fisher Scientific), FreMon Scientific, Inc., GE, Helmer Scientific, KW Apparecchi Scientifici, Sarstedt AG & Co. KG, Sartorius AG, and Thaw World Medical Ltd.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biomedical warming and thawing devices market analysis from 2021 to 2031 to identify the prevailing biomedical warming and thawing devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the biomedical warming and thawing devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global biomedical warming and thawing devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Manual
- Automatic
By Sample Type
- Blood Product
- Type
- Plasma
- RBC
- Stem cell
- Embryo
- Ovum
- Others
By End User
- Hospitals and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- Blood Banks and stem cell banks
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Barkey gmbh and co. kg
- BioLife Solutions
- BOEKEL SCIENTIFIC
- CARDINAL HEALTH
- Conroy Medical AB.
- Cytiva
- CytoTherm
- Eppendorf
- Farrar Scientific
- FISHER SCIENTIFIC PTE LTD
- FreMon Scientific, Inc.
- Helmer Scientific
- KW APPARECCHI SCIENTIFICI
- Sarstedt AG and Co. KG
- Sartorius AG
- ThawWorld Medical Ltd.
- General Electric Company
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY PRODUCT
CHAPTER 5: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY SAMPLE TYPE
CHAPTER 6: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY END USER
CHAPTER 7: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Biomedical Warming and Thawing Devices Market," the biomedical warming and thawing devices market size was valued at $159.30 million in 2021, and is estimated to reach $376.7 million by 2031, growing at a CAGR of 9.1% from 2022 to 2031. Cells and tissues are preserved by a process called cryopreservation, which uses very low temperatures. Cryopreserved items can be warmed and thawed with the help of biomedical warming and thawing equipment. Chemicals used in cryo-preservatives can harm living cells that have been kept for a longer time. Therefore, until complete thawing is achieved, they should be rapidly warmed from the frozen state. Before being transferred to a growing medium that has already been warmed, the frozen cells are quickly defrosted in a water bath at 37°C. To reduce the amount of time that cells are exposed to cryo-preservative substances, it is crucial to transfer the contents of the vials into the medium after defrosting. Therefore, warming and thawing devices are important to reduce the effect of cryo-preservatives on the cells, ensuring their viability for use in various purposes in healthcare and research.Factors that drive the biomedical warming and thawing devices market growth include, rise in the number of in-vitro fertilization technique and increase in the number of road traffic accidents. In addition, rise in the number of blood-related disorders that required blood transfusion is anticipated to fuel the growth of the market. Blood-related diseases, which require blood transfusion include, chronic anemia, bleeding disorder as hemophilia, blood cancer such as leukemia, lymphoma and myeloma. Rise in the number of blood-related disorders cause increase in the number of blood transfusion centers for storage of cryopreserved items. Thus, this factor is anticipated to fuel the biomedical warming and thawing devices market trends.
For instance, according to Leukemia & Lymphoma Society, in 2021, it was reported that, a total of 186,400 people in the U.S. are expected to be diagnosed with leukemia. As per the same source, new cases of leukemia were expected to account for 9.8% of the estimated 1,898,160 new cancer cases diagnosed in the U.S. in 2021. Moreover, biomedical warming and thawing devices are also used to maintain cryopreserved samples of ovum, semen, and embryo. Therefore, increase in prevalence of infertility among male and female population and rise in the number of in-vitro fertilization procedures are anticipated to fuel the demand for biomedical warming and thawing devices. In addition, technological advancement in the healthcare sector and rise in expenditure by government to develop healthcare infrastructure are anticipated to fuel the growth of the biomedical warming devices market. Increase in the number of blood donation campaign and rise in the number of blood banks, stem cell banks, and diagnostic centers fuels the demand for biomedical warming and thawing devices. Moreover, rise in the number of R&D activities and increase used of biomedical warming and thawing devices in biotechnology and pharmaceutical companies boost the biomedical thawing devices market growth.
On the basis of product, the market is classified into manual and automatic. The automatic segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in the usage of automatic warming and thawing device for storage of cryopreserved items and effectiveness of device to store them.
On the basis of sample, the market is classified into blood products, stem cell, embryo, ovum, and others. The blood product segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in the prevalence of blood-related disorders, rise in the activity of blood donation, and rise in the number of blood banks and blood transfusion centers.
On the basis of end user, the market is classified into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and blood banks & stem cell banks. The hospitals & diagnostic laboratories segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in the expenditure by government to develop healthcare infrastructure and rise in the number of hospitals & diagnostic laboratories.
North America accounted for a majority of the global biomedical warming and thawing devices market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to high presence of biomedical industry who manufacture biomedical warming and thawing device and technological advancement in the healthcare sector. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in the activity of blood donation, rise in the number of blood banks and blood transfusion centers, and increase in expenditure by government to develop the healthcare sector.
Key Findings of the Study
- By product, the automatic segment was the highest contributor to the market in 2021.
- By sample, the blood products segment was the highest contributor to the market in 2021.
- By end user, the hospitals & diagnostic laboratories banks segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
- By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Barkey GmbH and Co. Kg
- Biolife Solutions
- Boekel Scientific
- Cardinal Health
- Conroy Medical Ab.
- Cytiva
- Cytotherm
- Eppendorf
- Farrar Scientific
- Fisher Scientific Pte Ltd
- Fremon Scientific, Inc.
- Helmer Scientific
- Kw Apparecchi Scientifici
- Sarstedt AG and Co. Kg
- Sartorius AG
- Thawworld Medical Ltd.
- General Electric Company
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 326 |
| Published | August 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 159.3 million |
| Forecasted Market Value ( USD | $ 376.7 million |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
